Pheon Therapeutics

United Kingdom · Founded 2015 · Privately Held (backing)

Developer of advanced cancer treatment intended for targeting hard-to-treat cancers. Pheon Therapeutics is based in United Kingdom and was founded in 2015. Its last known valuation is $173 million. It has raised $191 million.

Last price · $/share
—
Implied valuation
$172.7M
Total raised
$191.1M
Last round
—

Who backs Pheon Therapeutics?

11 investors
InvestorType
Lightspeed Venture PartnersVenture capital
ForbionVenture capital
Perceptive AdvisorsHedge fund
Hostplus Superannuation FundCorporate
Atlas VentureOther
Brandon CapitalVenture capital
BVF Partners—
Brandon Biocatalyst—
King's College London—
Research Corporation Technologies—
+ 1 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Pheon Therapeutics investors

11 investors are on record for Pheon Therapeutics, including Lightspeed Venture Partners, Forbion, Perceptive Advisors and Hostplus Superannuation Fund. By type, the record holds 3 venture capital firms, 1 hedge fund and 1 corporate investor.

Free account
More of Pheon Therapeutics with a free account
  • ·The complete investor list: 11 names
  • ·Watch Pheon Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 11 firms already write checks for companies like Pheon Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View